Grifols inaugurates new plasma fractionation plant
The facility, which cost more than €20 millions, is located in the Parets del Vallès industrial park.
Catalan biotechnology group Grifols has inaugurated a new plasma fractionation plant in the Parets del Vallès industrial park (Barcelona). The facility cost more than €20 millions and will allow the company to fractionate 2.1 million liters of plasma each year. With this new plant, the Catalan multinational corporation will be able to double the amount of plasma fractionated in Spain, reaching approximately 4.2 million liters per year.
The new facility has already received authorization from the European Medicines Agency (EMA) and is expected to receive that of the US FDA later this year. With the additional 4,500 square meters, Grifols has announced it will be able to create 100 new jobs, both directly and indirectly.
Various political figures attended the official inauguration, including President of the Government of Catalonia Artur Mas, Catalan Minister of Health Boi Ruiz, Catalan Minister of Enterprise and Employment Felip Puig, and Mayor of Parets del Vallès Sergi Mingote. President and CEO of the company, Víctor Grífols, also attended the event.
In 2013, Grifols invested €5 millions in a new plant in Brazil, acquired 35% of US pharmaceutical company Aradigm and purchased the Novartis diagnostic unit for more than $1,600 millions, among other business milestones. The Catalan multinational corporation is the world’s third-largest producer of plasma derivatives.
More information is available in the Grifols press release.
- Related news (10/04/2013)
- Related news (28/05/2013)
- Related news (11/11/2013)